ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dolutegravir Sodium Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-5I9609
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Dolutegravir Sodium Market Insights and Forecast to 2028
BUY CHAPTERS

Global Dolutegravir Sodium Market Research Report 2025

Code: QYRE-Auto-5I9609
Report
September 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ViiV Healthcare UK
Emcure Pharmaceuticals
Aurobindo Pharma
Laurus Labs
Mylan NV
Adcock Ingram Limited
Ranbaxy Pharmaceuticals
Cipla Ltd

Dolutegravir Sodium Market

The global market for Dolutegravir Sodium was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Dolutegravir Sodium is an HIV integrase inhibitor that blocks the strand transfer step of the integration of the viral genome into the host cell. It works by preventing the virus from multiplying and spreading. Dolutegravir Sodium is used to treat HIV infection in adults and children who are at least 12 years old. It is also given to prevent HIV infection in people who have a high risk of getting the virus.
The future market trends of Dolutegravir Sodium are expected to be influenced by the following factors:The increasing incidence of HIV/AIDS, rising demand for better treatment options, and the growing number of approvals for Dolutegravir Sodium.The introduction of new drugs and formulations that may offer better efficacy and safety than Dolutegravir Sodium, such as long-acting injectable formulations, dual therapies, and novel integrase inhibitors.The expansion of the market in emerging regions, such as Asia-Pacific and Latin America, where Dolutegravir Sodium has been approved or is under review by regulatory authorities.The impact of the COVID-19 pandemic, which may increase the risk of HIV infection and affect the access and adherence to Dolutegravir Sodium treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dolutegravir Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dolutegravir Sodium.
The Dolutegravir Sodium market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dolutegravir Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dolutegravir Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dolutegravir Sodium Market Report

Report Metric Details
Report Name Dolutegravir Sodium Market
Segment by Type
  • Bottled Packaging
  • Film Coated Packaging
Segment by Application
  • AIDS Adult Patients
  • AIDS Children over 12 Years Old
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ViiV Healthcare UK, Emcure Pharmaceuticals, Aurobindo Pharma, LAURUS Labs, Mylan, Adcock Ingram Limited, Ranbaxy Pharmaceuticals, Cipla
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dolutegravir Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dolutegravir Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Dolutegravir Sodium Market report?

Ans: The main players in the Dolutegravir Sodium Market are ViiV Healthcare UK, Emcure Pharmaceuticals, Aurobindo Pharma, LAURUS Labs, Mylan, Adcock Ingram Limited, Ranbaxy Pharmaceuticals, Cipla

What are the Application segmentation covered in the Dolutegravir Sodium Market report?

Ans: The Applications covered in the Dolutegravir Sodium Market report are AIDS Adult Patients, AIDS Children over 12 Years Old

What are the Type segmentation covered in the Dolutegravir Sodium Market report?

Ans: The Types covered in the Dolutegravir Sodium Market report are Bottled Packaging, Film Coated Packaging

1 Dolutegravir Sodium Market Overview
1.1 Product Definition
1.2 Dolutegravir Sodium by Type
1.2.1 Global Dolutegravir Sodium Market Value Comparison by Type (2024 VS 2031)
1.2.2 Bottled Packaging
1.2.3 Film Coated Packaging
1.3 Dolutegravir Sodium by Application
1.3.1 Global Dolutegravir Sodium Market Value by Application (2024 VS 2031)
1.3.2 AIDS Adult Patients
1.3.3 AIDS Children over 12 Years Old
1.4 Global Dolutegravir Sodium Market Size Estimates and Forecasts
1.4.1 Global Dolutegravir Sodium Revenue 2020-2031
1.4.2 Global Dolutegravir Sodium Sales 2020-2031
1.4.3 Global Dolutegravir Sodium Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dolutegravir Sodium Market Competition by Manufacturers
2.1 Global Dolutegravir Sodium Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dolutegravir Sodium Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dolutegravir Sodium Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dolutegravir Sodium, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dolutegravir Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dolutegravir Sodium, Product Type & Application
2.7 Global Key Manufacturers of Dolutegravir Sodium, Date of Enter into This Industry
2.8 Global Dolutegravir Sodium Market Competitive Situation and Trends
2.8.1 Global Dolutegravir Sodium Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dolutegravir Sodium Players Market Share by Revenue
2.8.3 Global Dolutegravir Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dolutegravir Sodium Market Scenario by Region
3.1 Global Dolutegravir Sodium Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dolutegravir Sodium Sales by Region: 2020-2031
3.2.1 Global Dolutegravir Sodium Sales by Region: 2020-2025
3.2.2 Global Dolutegravir Sodium Sales by Region: 2026-2031
3.3 Global Dolutegravir Sodium Revenue by Region: 2020-2031
3.3.1 Global Dolutegravir Sodium Revenue by Region: 2020-2025
3.3.2 Global Dolutegravir Sodium Revenue by Region: 2026-2031
3.4 North America Dolutegravir Sodium Market Facts & Figures by Country
3.4.1 North America Dolutegravir Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dolutegravir Sodium Sales by Country (2020-2031)
3.4.3 North America Dolutegravir Sodium Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dolutegravir Sodium Market Facts & Figures by Country
3.5.1 Europe Dolutegravir Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dolutegravir Sodium Sales by Country (2020-2031)
3.5.3 Europe Dolutegravir Sodium Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dolutegravir Sodium Market Facts & Figures by Region
3.6.1 Asia Pacific Dolutegravir Sodium Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dolutegravir Sodium Sales by Region (2020-2031)
3.6.3 Asia Pacific Dolutegravir Sodium Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dolutegravir Sodium Market Facts & Figures by Country
3.7.1 Latin America Dolutegravir Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dolutegravir Sodium Sales by Country (2020-2031)
3.7.3 Latin America Dolutegravir Sodium Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dolutegravir Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Dolutegravir Sodium Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dolutegravir Sodium Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dolutegravir Sodium Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dolutegravir Sodium Sales by Type (2020-2031)
4.1.1 Global Dolutegravir Sodium Sales by Type (2020-2025)
4.1.2 Global Dolutegravir Sodium Sales by Type (2026-2031)
4.1.3 Global Dolutegravir Sodium Sales Market Share by Type (2020-2031)
4.2 Global Dolutegravir Sodium Revenue by Type (2020-2031)
4.2.1 Global Dolutegravir Sodium Revenue by Type (2020-2025)
4.2.2 Global Dolutegravir Sodium Revenue by Type (2026-2031)
4.2.3 Global Dolutegravir Sodium Revenue Market Share by Type (2020-2031)
4.3 Global Dolutegravir Sodium Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dolutegravir Sodium Sales by Application (2020-2031)
5.1.1 Global Dolutegravir Sodium Sales by Application (2020-2025)
5.1.2 Global Dolutegravir Sodium Sales by Application (2026-2031)
5.1.3 Global Dolutegravir Sodium Sales Market Share by Application (2020-2031)
5.2 Global Dolutegravir Sodium Revenue by Application (2020-2031)
5.2.1 Global Dolutegravir Sodium Revenue by Application (2020-2025)
5.2.2 Global Dolutegravir Sodium Revenue by Application (2026-2031)
5.2.3 Global Dolutegravir Sodium Revenue Market Share by Application (2020-2031)
5.3 Global Dolutegravir Sodium Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ViiV Healthcare UK
6.1.1 ViiV Healthcare UK Company Information
6.1.2 ViiV Healthcare UK Description and Business Overview
6.1.3 ViiV Healthcare UK Dolutegravir Sodium Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ViiV Healthcare UK Dolutegravir Sodium Product Portfolio
6.1.5 ViiV Healthcare UK Recent Developments/Updates
6.2 Emcure Pharmaceuticals
6.2.1 Emcure Pharmaceuticals Company Information
6.2.2 Emcure Pharmaceuticals Description and Business Overview
6.2.3 Emcure Pharmaceuticals Dolutegravir Sodium Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Emcure Pharmaceuticals Dolutegravir Sodium Product Portfolio
6.2.5 Emcure Pharmaceuticals Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Company Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Dolutegravir Sodium Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aurobindo Pharma Dolutegravir Sodium Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 LAURUS Labs
6.4.1 LAURUS Labs Company Information
6.4.2 LAURUS Labs Description and Business Overview
6.4.3 LAURUS Labs Dolutegravir Sodium Sales, Revenue and Gross Margin (2020-2025)
6.4.4 LAURUS Labs Dolutegravir Sodium Product Portfolio
6.4.5 LAURUS Labs Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Dolutegravir Sodium Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Dolutegravir Sodium Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Adcock Ingram Limited
6.6.1 Adcock Ingram Limited Company Information
6.6.2 Adcock Ingram Limited Description and Business Overview
6.6.3 Adcock Ingram Limited Dolutegravir Sodium Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Adcock Ingram Limited Dolutegravir Sodium Product Portfolio
6.6.5 Adcock Ingram Limited Recent Developments/Updates
6.7 Ranbaxy Pharmaceuticals
6.7.1 Ranbaxy Pharmaceuticals Company Information
6.7.2 Ranbaxy Pharmaceuticals Description and Business Overview
6.7.3 Ranbaxy Pharmaceuticals Dolutegravir Sodium Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ranbaxy Pharmaceuticals Dolutegravir Sodium Product Portfolio
6.7.5 Ranbaxy Pharmaceuticals Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Company Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla Dolutegravir Sodium Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cipla Dolutegravir Sodium Product Portfolio
6.8.5 Cipla Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dolutegravir Sodium Industry Chain Analysis
7.2 Dolutegravir Sodium Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dolutegravir Sodium Production Mode & Process Analysis
7.4 Dolutegravir Sodium Sales and Marketing
7.4.1 Dolutegravir Sodium Sales Channels
7.4.2 Dolutegravir Sodium Distributors
7.5 Dolutegravir Sodium Customer Analysis
8 Dolutegravir Sodium Market Dynamics
8.1 Dolutegravir Sodium Industry Trends
8.2 Dolutegravir Sodium Market Drivers
8.3 Dolutegravir Sodium Market Challenges
8.4 Dolutegravir Sodium Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ViiV Healthcare UK
Emcure Pharmaceuticals
Aurobindo Pharma
Laurus Labs
Mylan NV
Adcock Ingram Limited
Ranbaxy Pharmaceuticals
Cipla Ltd
List of Tables
 Table 1. Global Dolutegravir Sodium Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dolutegravir Sodium Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dolutegravir Sodium Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dolutegravir Sodium Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Dolutegravir Sodium Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dolutegravir Sodium Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dolutegravir Sodium Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dolutegravir Sodium Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dolutegravir Sodium, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dolutegravir Sodium, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dolutegravir Sodium, Product Type & Application
 Table 12. Global Key Manufacturers of Dolutegravir Sodium, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dolutegravir Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dolutegravir Sodium as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dolutegravir Sodium Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dolutegravir Sodium Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Dolutegravir Sodium Sales Market Share by Region (2020-2025)
 Table 19. Global Dolutegravir Sodium Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Dolutegravir Sodium Sales Market Share by Region (2026-2031)
 Table 21. Global Dolutegravir Sodium Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dolutegravir Sodium Revenue Market Share by Region (2020-2025)
 Table 23. Global Dolutegravir Sodium Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dolutegravir Sodium Revenue Market Share by Region (2026-2031)
 Table 25. North America Dolutegravir Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dolutegravir Sodium Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Dolutegravir Sodium Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Dolutegravir Sodium Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dolutegravir Sodium Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dolutegravir Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dolutegravir Sodium Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Dolutegravir Sodium Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Dolutegravir Sodium Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dolutegravir Sodium Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dolutegravir Sodium Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dolutegravir Sodium Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Dolutegravir Sodium Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Dolutegravir Sodium Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dolutegravir Sodium Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dolutegravir Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dolutegravir Sodium Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Dolutegravir Sodium Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Dolutegravir Sodium Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dolutegravir Sodium Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dolutegravir Sodium Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dolutegravir Sodium Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Dolutegravir Sodium Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Dolutegravir Sodium Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dolutegravir Sodium Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dolutegravir Sodium Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Dolutegravir Sodium Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Dolutegravir Sodium Sales Market Share by Type (2020-2025)
 Table 53. Global Dolutegravir Sodium Sales Market Share by Type (2026-2031)
 Table 54. Global Dolutegravir Sodium Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dolutegravir Sodium Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dolutegravir Sodium Revenue Market Share by Type (2020-2025)
 Table 57. Global Dolutegravir Sodium Revenue Market Share by Type (2026-2031)
 Table 58. Global Dolutegravir Sodium Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Dolutegravir Sodium Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Dolutegravir Sodium Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Dolutegravir Sodium Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Dolutegravir Sodium Sales Market Share by Application (2020-2025)
 Table 63. Global Dolutegravir Sodium Sales Market Share by Application (2026-2031)
 Table 64. Global Dolutegravir Sodium Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dolutegravir Sodium Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dolutegravir Sodium Revenue Market Share by Application (2020-2025)
 Table 67. Global Dolutegravir Sodium Revenue Market Share by Application (2026-2031)
 Table 68. Global Dolutegravir Sodium Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Dolutegravir Sodium Price (USD/Pcs) by Application (2026-2031)
 Table 70. ViiV Healthcare UK Company Information
 Table 71. ViiV Healthcare UK Description and Business Overview
 Table 72. ViiV Healthcare UK Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. ViiV Healthcare UK Dolutegravir Sodium Product
 Table 74. ViiV Healthcare UK Recent Developments/Updates
 Table 75. Emcure Pharmaceuticals Company Information
 Table 76. Emcure Pharmaceuticals Description and Business Overview
 Table 77. Emcure Pharmaceuticals Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Emcure Pharmaceuticals Dolutegravir Sodium Product
 Table 79. Emcure Pharmaceuticals Recent Developments/Updates
 Table 80. Aurobindo Pharma Company Information
 Table 81. Aurobindo Pharma Description and Business Overview
 Table 82. Aurobindo Pharma Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Aurobindo Pharma Dolutegravir Sodium Product
 Table 84. Aurobindo Pharma Recent Developments/Updates
 Table 85. LAURUS Labs Company Information
 Table 86. LAURUS Labs Description and Business Overview
 Table 87. LAURUS Labs Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. LAURUS Labs Dolutegravir Sodium Product
 Table 89. LAURUS Labs Recent Developments/Updates
 Table 90. Mylan Company Information
 Table 91. Mylan Description and Business Overview
 Table 92. Mylan Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Mylan Dolutegravir Sodium Product
 Table 94. Mylan Recent Developments/Updates
 Table 95. Adcock Ingram Limited Company Information
 Table 96. Adcock Ingram Limited Description and Business Overview
 Table 97. Adcock Ingram Limited Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Adcock Ingram Limited Dolutegravir Sodium Product
 Table 99. Adcock Ingram Limited Recent Developments/Updates
 Table 100. Ranbaxy Pharmaceuticals Company Information
 Table 101. Ranbaxy Pharmaceuticals Description and Business Overview
 Table 102. Ranbaxy Pharmaceuticals Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Ranbaxy Pharmaceuticals Dolutegravir Sodium Product
 Table 104. Ranbaxy Pharmaceuticals Recent Developments/Updates
 Table 105. Cipla Company Information
 Table 106. Cipla Description and Business Overview
 Table 107. Cipla Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Cipla Dolutegravir Sodium Product
 Table 109. Cipla Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Dolutegravir Sodium Distributors List
 Table 113. Dolutegravir Sodium Customers List
 Table 114. Dolutegravir Sodium Market Trends
 Table 115. Dolutegravir Sodium Market Drivers
 Table 116. Dolutegravir Sodium Market Challenges
 Table 117. Dolutegravir Sodium Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dolutegravir Sodium
 Figure 2. Global Dolutegravir Sodium Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dolutegravir Sodium Market Share by Type: 2024 & 2031
 Figure 4. Bottled Packaging Product Picture
 Figure 5. Film Coated Packaging Product Picture
 Figure 6. Global Dolutegravir Sodium Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Dolutegravir Sodium Market Share by Application: 2024 & 2031
 Figure 8. AIDS Adult Patients
 Figure 9. AIDS Children over 12 Years Old
 Figure 10. Global Dolutegravir Sodium Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Dolutegravir Sodium Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Dolutegravir Sodium Sales (2020-2031) & (K Pcs)
 Figure 13. Global Dolutegravir Sodium Average Price (USD/Pcs) & (2020-2031)
 Figure 14. Dolutegravir Sodium Report Years Considered
 Figure 15. Dolutegravir Sodium Sales Share by Manufacturers in 2024
 Figure 16. Global Dolutegravir Sodium Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Dolutegravir Sodium Players: Market Share by Revenue in Dolutegravir Sodium in 2024
 Figure 18. Dolutegravir Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Dolutegravir Sodium Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Dolutegravir Sodium Sales Market Share by Country (2020-2031)
 Figure 21. North America Dolutegravir Sodium Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Dolutegravir Sodium Sales Market Share by Country (2020-2031)
 Figure 25. Europe Dolutegravir Sodium Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Dolutegravir Sodium Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Dolutegravir Sodium Revenue Market Share by Region (2020-2031)
 Figure 33. China Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Dolutegravir Sodium Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Dolutegravir Sodium Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Dolutegravir Sodium Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Dolutegravir Sodium Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Dolutegravir Sodium Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Dolutegravir Sodium by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Dolutegravir Sodium by Type (2020-2031)
 Figure 55. Global Dolutegravir Sodium Price (USD/Pcs) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Dolutegravir Sodium by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Dolutegravir Sodium by Application (2020-2031)
 Figure 58. Global Dolutegravir Sodium Price (USD/Pcs) by Application (2020-2031)
 Figure 59. Dolutegravir Sodium Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Dolutegravir Market Research Report 2024
Global Dolutegravir and Its Combination Drug Market Research Report 2024
Global Dolutegravir and Dolutegravir Generic Drug Market Research Report 2025
Global Dolutegravir Rilpivirine Combination Drug Market Research Report 2024
Global Dalteparin Sodium Market Research Report 2025
Global Sodium Laurate Market Research Report 2025
Global Dalteparin Sodium API Market Research Report 2025
Global Beraprost Sodium Tablets Market Research Report 2024
Global Naproxen Sodium Market Research Report 2024
Global Pravastatin Sodium Market Research Report 2025
Global Sugammadex Sodium Market Research Report 2025
Global Fondaparinux Sodium Market Research Report 2024
Global Sodium Dehydroacetate Market Research Report 2025
Global Ozagrel Sodium for Injection Market Research Report 2024
Global Diclofenac Sodium API Market Research Report 2025
Global Resazurin Sodium Salt Market Research Report 2025
Global Sodium Adipate Market Research Report 2024
Global Glecaprevir Market Research Report 2025
Sacubitril Sodium Market
Global Pravastatin Sodium Tablets Market Research Report 2024

RELATED REPORTS

Global Nano Porous Silicon–carbon Anode Material Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0F17509
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Foam Board Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16F19834
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Copper Wires Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5U6954
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Quartz Fiber Cloth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20G17359
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions